drugset / Trial / NCT03106389

Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy

NCT03106389

Phase 4 Unknown 108 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled study will be performed to compare the benefits and risks associated with the administration of misoprostol with or without the use of a transcervical balloon catheter to terminate pregnancy in the second trimester (defined as gestational age between 14 and 28 weeks of gestation).

Timeline

Start
2017-03-01
Primary completion
2017-06-30
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Background Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.